Administering antihypertensive drugs after acute ischemic stroke: Timing is everything

CMAJ. Canadian Medical Association Journal

Volumn 172, Issue 5, 2005, Pages 625-626

  Semplicini, Andrea ^a   Calò, Lorenzo ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; LABETALOL; NITROPRUSSIDE SODIUM;

ACUTE DISEASE; ANTIHYPERTENSIVE ACTIVITY; AUTOREGULATION; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CARDIOVASCULAR RESPONSE; EXPERIENCE; HUMAN; HYPERTENSION; SHORT SURVEY; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 14844285374     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1041393     Document Type: Short Survey

References (4)

1. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA; IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002;33(5):1315-20.
2. Castillo J, Leira R, Garcia MM, Serena J, Blanco M, Davalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004;35(2):520-6.
3. Semplicini A, Maresca A, Boscolo G, Sartori M, Rocchi R, Giantin V, et al. Hypertension in acute ischemic stroke: A compensatory mechanism or an additional damaging factor? Arch Intern Med 2003;163(2):211-6.
4. Klijn CJ, Hankey GJ: American Stroke Association and European Stroke Initiative Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative. Lancet Neurol 2003;2(11):698-701.